Perioperative blood transfusion has distinct postsurgical oncologic impact on patients with different stage of hepatocellular carcinoma

[1]  P. Schirmacher,et al.  EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. , 2018, Journal of hepatology.

[2]  Y. Liang,et al.  No impact of perioperative blood transfusion on prognosis after curative resection for hepatocellular carcinoma: a propensity score matching analysis , 2018, Clinical and Translational Oncology.

[3]  M. Dahmer,et al.  Mechanisms of red blood cell transfusion‐related immunomodulation , 2018, Transfusion.

[4]  Publisher's Note , 2018, Anaesthesia.

[5]  Yong-Gyu Park,et al.  Prognostic factors after curative resection hepatocellular carcinoma and the surgeon's role , 2017, Annals of surgical treatment and research.

[6]  J. Shindoh,et al.  Prognostic impact of complications after resection of early stage hepatocellular carcinoma , 2017, Journal of surgical oncology.

[7]  J. Seghatchian,et al.  Transfusion-related immunomodulation and cancer. , 2017, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[8]  Shan Huang,et al.  Lymphocyte to monocyte ratio and neutrophil to lymphocyte ratio are superior inflammation‐based predictors of recurrence in patients with hepatocellular carcinoma after hepatic resection , 2017, Journal of surgical oncology.

[9]  S. Shen,et al.  Anatomical versus non‐anatomical liver resection for hepatocellular carcinoma exceeding Milan criteria , 2017, The British journal of surgery.

[10]  T. Sugiura,et al.  Neutrophil to lymphocyte ratio as an indicator of the malignant behaviour of hepatocellular carcinoma , 2016, The British journal of surgery.

[11]  J. Bruix,et al.  Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma. , 2016, Gastroenterology.

[12]  G. Chen,et al.  Preoperative serum α‐fetoprotein and prognosis after hepatectomy for hepatocellular carcinoma , 2016, The British journal of surgery.

[13]  W. Lau,et al.  Perioperative blood transfusion does not influence recurrence-free and overall survivals after curative resection for hepatocellular carcinoma: A Propensity Score Matching Analysis. , 2016, Journal of hepatology.

[14]  A. Jemal,et al.  Cancer statistics in China, 2015 , 2016, CA: a cancer journal for clinicians.

[15]  G. Song,et al.  The Impact of Tumor Size on Long-Term Survival Outcomes After Resection of Solitary Hepatocellular Carcinoma: Single-Institution Experience with 2558 Patients , 2015, Journal of Gastrointestinal Surgery.

[16]  B. Sangro,et al.  Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  Rolf H H Groenwold,et al.  Reporting of covariate selection and balance assessment in propensity score analysis is suboptimal: a systematic review. , 2015, Journal of clinical epidemiology.

[18]  Y. Hao,et al.  Preoperative Aspartate Aminotransferase to Platelet Ratio is an Independent Prognostic Factor for Hepatitis B-Induced Hepatocellular Carcinoma After Hepatic Resection , 2014, Annals of Surgical Oncology.

[19]  M. Sata,et al.  The Significance of Classifying Microvascular Invasion in Patients with Hepatocellular Carcinoma , 2014, Annals of Surgical Oncology.

[20]  Suqing Zhang,et al.  Perioperative Allogenenic Blood Transfusion Is Associated with Worse Clinical Outcomes for Hepatocellular Carcinoma: A Meta-Analysis , 2013, PloS one.

[21]  P. Chow,et al.  Systematic review of outcomes of liver resection for early hepatocellular carcinoma within the Milan criteria , 2012, The British journal of surgery.

[22]  H. Ohdan,et al.  No Impact of Perioperative Blood Transfusion on Recurrence of Hepatocellular Carcinoma after Hepatectomy , 2012, World Journal of Surgery.

[23]  S. Fan,et al.  Continuous Improvement of Survival Outcomes of Resection of Hepatocellular Carcinoma: A 20-Year Experience , 2011, Annals of surgery.

[24]  Elizabeth A Stuart,et al.  Matching methods for causal inference: A review and a look forward. , 2010, Statistical science : a review journal of the Institute of Mathematical Statistics.

[25]  M. Makuuchi,et al.  Scenario 1 : Complication After a Surgical Procedure Not Caused by a Surgeon , 2022 .

[26]  T. Misawa,et al.  Negative Impact of Blood Transfusion on Recurrence and Prognosis of Hepatocellular Carcinoma After Hepatic Resection , 2009, Journal of Gastrointestinal Surgery.

[27]  G. Ercolani,et al.  Trends in Perioperative Outcome After Hepatic Resection: Analysis of 1500 Consecutive Unselected Cases Over 20 Years , 2009, Annals of surgery.

[28]  M. Gonen,et al.  Operative Blood Loss Independently Predicts Recurrence and Survival After Resection of Hepatocellular Carcinoma , 2009, Annals of surgery.

[29]  J. Avorn,et al.  Variable selection for propensity score models. , 2006, American journal of epidemiology.

[30]  N. Nagasue,et al.  The influence of perioperative blood transfusion on intrahepatic recurrence after curative resection of hepatocellular carcinoma , 2000, American Journal of Gastroenterology.

[31]  N. Nagasue,et al.  The influence of perioperative blood transfusion on intrahepatic recurrence after curative resection of hepatocellular carcinoma. , 2000 .

[32]  K. Dohi,et al.  Perioperative Blood Transfusion as a Prognostic Indicator in Patients with Hepatocellular Carcinoma , 1999, World Journal of Surgery.

[33]  R. D'Agostino.  Adjustment Methods: Propensity Score Methods for Bias Reduction in the Comparison of a Treatment to a Non‐Randomized Control Group , 2005 .

[34]  D B Rubin,et al.  Matching using estimated propensity scores: relating theory to practice. , 1996, Biometrics.

[35]  M. Makuuchi,et al.  Perioperative blood transfusion promotes recurrence of hepatocellular carcinoma after hepatectomy. , 1994, Surgery.

[36]  G. Dusheiko,et al.  Management of hepatocellular carcinoma. , 1992, Journal of hepatology.

[37]  M. Dumont,et al.  European Association for the Study of the Liver , 1971 .

[38]  H. Eguchi,et al.  Perioperative allogenic blood transfusion is a poor prognostic factor after hepatocellular carcinoma surgery: a multi-center analysis , 2017, Surgery Today.

[39]  M. Kudo,et al.  The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma. , 2017, Journal of hepatology.

[40]  C. Chan,et al.  Importance of tumor size as a prognostic factor after partial liver resection for solitary hepatocellular carcinoma: Implications on the current AJCC staging system , 2016, Journal of surgical oncology.

[41]  Y. Maehara,et al.  Blood Transfusion is Associated with Recurrence of Hepatocellular Carcinoma After Hepatectomy in Child–Pugh Class A Patients , 2014, World Journal of Surgery.

[42]  Riccardo Lencioni,et al.  EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. , 2012, Journal of hepatology.

[43]  V. Preedy,et al.  European Organization for Research and Treatment of Cancer , 2010 .

[44]  D. Spahn,et al.  Allogeneic blood transfusions: benefit, risks and clinical indications in countries with a low or high human development index. , 2004, British medical bulletin.